0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

ATROPHY OF THE LIVER DUE TO CINCHOPHEN PREPARATIONS

JAMA. 1930;95(5):345-346. doi:10.1001/jama.1930.02720050033013.
Text Size: A A A
Published online

ABSTRACT

When cinchophen, or phenylcinchoninic acid, was introduced into therapeutics, about 1908 (reinforced by the trade name "Atophan"—the tophi remover), its striking effect on the elimination of uric acid captured the clinical imagination, which was at that time perhaps somewhat overconscious of uric acid. The product attained immediate popularity. The uric acid complex receded, and it was soon seen that atophan belied its name, for the tophi proved unreasonable and refused to be removed. The drug was found, however, to be an effective analgesic, much like the salicylates, with which it has many points of similarity. Since the taste is different, the popularity of cinchophen continued to increase, so much so that it achieved a place in the United States Pharmacopeia. Various esters and derivatives were advertised extensively for the benefit of those who do not like the flavor of cinchophen and incidentally for the benefit of the manufacturers, who could

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();